Targeting mTOR for cancer therapy

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Mechanistic target of rapamycin (mTOR) is a key protein kinase regulating fundamental cellular processes like growth, metabolism, and immunity.
• mTOR functions within complexes (mTORC1/2) and phosphorylates numerous targets, influencing protein synthesis, nutrient metabolism, and growth factor signaling.
• Aberrant mTOR activation is implicated in promoting tumor growth and metastasis, making it a significant target in cancer research.

Purpose of the Study:

• To provide an updated review of recent advances in understanding mTOR signaling pathways.
• To summarize the development of mTOR inhibitors for cancer therapy.
• To discuss the mechanisms of resistance to mTOR inhibitors in cancer cells.

Main Methods:

• Literature review of recent scientific publications on mTOR signaling and cancer therapy.
• Analysis of the roles of mTOR complexes and their targets in cellular regulation.
• Synthesis of information on approved and investigational mTOR inhibitors.

Main Results:

• mTOR signaling is critical for cell growth, survival, metabolism, and immunity, with dysregulation driving cancer progression.
• Numerous mTOR inhibitors have been developed, with some approved for clinical use, while others are in ongoing trials.
• Understanding resistance mechanisms is crucial for optimizing mTOR-targeted cancer therapies.

Conclusions:

• mTOR signaling is a vital regulator of cellular functions and a significant driver of cancer.
• mTOR inhibitors represent a promising therapeutic strategy for various cancers.
• Further research into resistance mechanisms is essential for improving the efficacy of mTOR-targeted treatments.